Review of Neuromodulation Techniques and Technological Limitations

Henry, Rabinder; Deckert, Martin; Guruviah, Velmathi; Schmidt, Bertram

doi:10.1080/02564602.2015.1106926

Cited by 16 publications

(5 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…70 Acoustic stimulation, especially through non-invasive methods like focus ultrasound (FUS), possesses the capacity to penetrate deep tissues (450 mm) with a spatial resolution inversely related to the penetration depth (in general 41 mm 3 and temporal precision 410 ms). 71,72 Furthermore, magnetic fields are recognized for their non-invasiveness and ability to access deep brain regions with little attenuation, presenting clinical pathways for treating neurological and psychiatric disorders. 73 The strategies to fabricate the controlled-release systems in response to these external stimuli are pretty similar to those used in drug delivery.…”

Section: Stimuli-responsive Controlled Release Systems For Neuromodul...mentioning

confidence: 99%

Recent advances in stimuli-responsive controlled release systems for neuromodulation

Shi,

Tan,

et al. 2024

J. Mater. Chem. B

View full text Add to dashboard Cite

show abstract

Section: Stimuli-responsive Controlled Release Systems For Neuromodul...mentioning

confidence: 99%

Recent advances in stimuli-responsive controlled release systems for neuromodulation

Shi,

Tan,

et al. 2024

J. Mater. Chem. B

View full text Add to dashboard Cite

show abstract

“…Neuromodulation may be undertaken by enhancing, suppressing, adjusting, and regulating neural activity and functioning (Henry et al, 2016) and is primarily used to treat disorders known to be under the influence of atypical nervous system functionality. Neuromodulation techniques are generally classed as being invasive (i.e., a surgical procedure is used to implant a stimulation device) or non-invasive (i.e., stimulation electrodes are placed on the cranium and removed after each session).…”

Section: Neuromodulation Treatmentmentioning

confidence: 99%

Current Status of Psychopharmacological, Neuromodulation, and Oxytocin Treatments for Autism: Implications for Clinical Practice

Bitsika,

Sharpley

2023

Adv Neurodev Disord

View full text Add to dashboard Cite

Objectives To provide an overview of the current literature regarding the neurobiological treatments of psychopharmacology, neuromodulation, oxytocin therapy, and psychological resilience, as treatments for autism-related difficulties, and to distil the research findings from those treatments for everyday clinical application. Methods Instead of producing another specific systematic summary of the efficacy of these treatments, this review took an overview of each field of research, identified its key research findings, and evaluated the treatment-ready status of each of them in terms of their evidence base. From this information, a set of recommendations were derived for their clinical applications, so as to inform practice in the field. Results These treatments represent relatively recent and neurobiologically based approaches to the challenges of autism, and are in the development stage. Each treatment is promising, and has some evidential basis for its success, but all need further research to establish their evidence-based validity for everyday clinical usage. Conclusions While most of these treatments can be applied with caution, clinicians should acknowledge their restrictive benefits and costs, that are described herein. Within those caveats, each of these treatments should be considered as an emerging therapy that clinicians should consider utilising in appropriate settings and with specific cases.

show abstract

“…In this section we will be briefly covering 3 alternative modalities: optogenetics, acoustic and thermal. Other modalities such as chemical or magnetic stimulation have been demonstrated but are outside the implantable and electronic focus of this book, a review can be found in [41,64].…”

Section: Alternative Approaches and Modalitiesmentioning

confidence: 99%

Next Generation Neural Interface Electronics

Williams¹,

Leene²,

Constandinou³

2022

Circuit Design Considerations for Implantable Devices

View full text Add to dashboard Cite

Key aspects of achieving this stable performance include the electrodes and the implant packaging, however, this chapter focuses on the electronics aspects. In depth reviews and recent developments of recent electrode development can be found in [29,45,71,90,114] and of packaging can be found in [35,96,98,104,108]. There are also basic architectural challenges involved in scaling-up to hundreds or thousands of channels -for instance floating electrodes (i.e., with wires between the electrodes and electronics)

show abstract

Review of Neuromodulation Techniques and Technological Limitations

Cited by 16 publications

References 42 publications

Recent advances in stimuli-responsive controlled release systems for neuromodulation

Recent advances in stimuli-responsive controlled release systems for neuromodulation

Current Status of Psychopharmacological, Neuromodulation, and Oxytocin Treatments for Autism: Implications for Clinical Practice

Next Generation Neural Interface Electronics

Contact Info

Product

Resources

About